A clinical trial to study the effects of two drugs,Etodolac and Thiocolchicoside in patients with acute painful musculospastic conditions.

Phase 3

Completed

• Registration Number: CTRI/2009/091/001094
• Lead Sponsor: M/s. Ravenbhel Healthcare Pvt. Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

Subjects of either sex of age  18 and  60 years [both inclusive]
Willing to give written informed consent
Subjects suffering from acute painful conditions with spasm such as prolapsed intervertebral disc, sprains and dislocations, spondylosis (lumbar, cervical, ankylosing spondylosis), spinal stenosis, Periarthritis, frozen shoulder, prepatellar bursistis, spondylilistheisis, Low-back pain, Tendonitis, Tenosynovitis, Bursitis.

Exclusion Criteria

Subjects currently on any other NSAID therapy.
Subjects who are unresponsive to conservative medical therapy due to severe symptoms and who require different pain medication ere excluded from the study.
Subjects with a history of known hypersensitivity from any one of the study medication.
Subjects with hepatic, renal, respiratory illness.
Subjects with active peptic ulcer disease.
Subjects presently having active GERD.
Subjects with history of bleeding tendencies, internal bleeding.
Subjects with anemia.
Subjects with uncontrolled hypertension.
Subjects with congestive heart failure.
Pregnant and Lactating women.
Participation in a clinical trial with an investigational agent during the past 30 days.
Simultaneous participation in a clinical study.
Severe uncontrolled systemic disease.
Drug dependents and alcoholics.
Subjects not willing to comply with protocol requirements.
Subjects with recent history of cardiovascular surgery.

Study & Design

• Study Type: Interventional
• Study Design: Not specified